Leonor Stephens

Leonor Stephens, Ph.D., MSL-BC has a strong background in scientific publications and clinical science liaison roles. Leonor is currently serving as an Associate Director of Scientific Publications at Blueprint Medicines. Prior to this, they worked as an Associate Director of Global Publications and a Clinical Science Liaison at TG Therapeutics, Inc. Leonor also gained experience as the Multiple Myeloma Program Coordinator at the University of Chicago Medicine. Leonor started their career as a Ph.D. candidate at Duke University, focusing on the role of acute injury in tumor development in a genetically engineered mouse model of soft tissue sarcoma.

Leonor Stephens, Ph.D., MSL-BC, earned a Bachelor of Arts (B.A.) degree in Biology, Molecular Biology/Biochemistry from Macalester College in 2010. Leonor then obtained their Doctor of Philosophy (PhD) degree in Molecular Cancer Biology from Duke University School of Medicine in 2015. Prior to their undergraduate studies, they completed their high school diploma at UWC-USA in 2006. In addition to their degrees, Leonor has obtained certifications in GCP and ICH in 2015 and Medical Science Liaison-Board Certification (MSL-BC®) from the Medical Science Liaison Society in 2020.